Please use this identifier to cite or link to this item: https://saber.ucv.ve/jspui/handle/10872/14532
Full metadata record
DC FieldValueLanguage
dc.contributor.authorEcheverria de Pérez, G.-
dc.contributor.authorLoreto, O.-
dc.contributor.authorBianco Colmenares, Nicolás E.-
dc.contributor.authorMéndez-Castellanos, H.-
dc.contributor.authorBurczak, J .D.-
dc.contributor.authorLee, H.-
dc.date.accessioned2017-02-20T21:12:14Z-
dc.date.available2017-02-20T21:12:14Z-
dc.date.issued1992-
dc.identifier.issn1931-8405-
dc.identifier.urihttp://hdl.handle.net/10872/14532-
dc.description.abstractTwo major groups of retroviruses, whose distribution varies geographically, are the cause of several human diseases. The human T- Iymphotropic virus type I (HTLV-I) is the etiologic agent for both adult T-cell leukemia/lymphoma and HTLV-I- associated myelopathy. HTLV-II has been linked to a certain type of hairy cell leukemia; however, its role in disease remains uncertain. HTLV-I is endemic in Japan, the Caribbean. And Africa; while both HTLV-I and HTLV-II have been reported in the United States and Italy, predominantly among intravenous drug abusers. Recently, HTLV-II infection has been demonstrated among certain American Indian groups in the United States and Panama.en_US
dc.language.isoenen_US
dc.publisherAIDS RESEARCH AND HUMAN RETROVIRUSESen_US
dc.relation.ispartofseriesVol. 8;No. 2-
dc.subjectretrovirusesen_US
dc.subjecthuman diseasesen_US
dc.subjectT-cellen_US
dc.subjectleukemiaen_US
dc.subjectlymphomaen_US
dc.subjectHTLV-I-en_US
dc.subjectmyelopathyen_US
dc.subjectHTLV-IIen_US
dc.titleLetter to the Editor Reappraisal of Human Retroviral Infection in Venezuelaen_US
dc.typeArticleen_US
Appears in Collections:Artículos Publicados

Files in This Item:
File Description SizeFormat 
Documento 52.pdf4.08 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.